FDA Releases Update of Test Substitution Tool Identifying Validated Supply Alternatives for SARS-CoV-2 Testing
![FDA updates direction on alternative COVID-19 testing supplies](https://covid19briefings.com/wp-content/uploads/2020/06/AS_255771503-lab-test-supply-substitution-graphic-flat.jpg)
The FDA recently updated its interactive tool designed to assist in identifying COVID-19 testing supply alternatives.
New Meta-analysis Reveals Significant Weaknesses in Evidence Base for Point-of-Care SARS-CoV-2 Serology Tests
![Clinical laboratories and meta-analysis recently published casts doubts on serology test performance, Abbott antigen test](https://covid19briefings.com/wp-content/uploads/2020/07/AS_276691406-meta-analysis-of-serology-test-performance-sm.jpeg)
New research casts doubt on the evidence that SARS-CoV-2 serology testing yields useful data.